Skip to main content

Advertisement

Table 1 Baseline patient profile

From: Safety and efficacy of biocompatible perfusion strategy in a contemporary series of patients undergoing coronary artery bypass grafting – a two-center study

Variable Percent or mean, SD (Median, Range), (n = 964)
Age (Years) 66 ± 11 (66, 32–89)
Gender (M/F) 804 (83%) / 160 (17%)
Hypertension 694 (72%)
Diabetes mellitus 345 (36%)
Peripheral vascular disease 184 (19%)
Prior cerebrovascular accident 62 (6%)
Renal failure on dialysis 13 (1.3%)
Chronic obstructive pulmonary disease 90 (9%)
Prior myocardial infarction 556 (58%)
Prior Percutaneous Coronary Intervention 282 (29%)
Preoperative intra-aortic balloon pump 42 (4.3%)
Preoperative medications  
 Aspirin 878 (91%)
 Second antiplatelet agent within 5 days 36 (4%)
 Heparin 342 (35%)
 Anti-arrhythmic medication 32 (3%)
 Immunosuppression 19 (2%)
Left ventricular ejection fraction (%) 53 ± 12 (55, 5–86)
Extent of coronary artery disease  
 Left main disease 386 (40%)
 Single vessel 48 (5%)
 Two vessel 287 (30%)
 Three vessel 628 (65%)